Avanos Medical (AVNS) Income from Continuing Operations (2013 - 2026)
Avanos Medical (AVNS) reported Income from Continuing Operations of 5100000.0 for Q1 2026, down 22.73% on a YoY basis from 6600000.0 in Q1 2025, and up 492.31% sequentially from 1300000.0 in Q4 2025.
Avanos Medical (AVNS) Income from Continuing Operations (2013 - 2026) Analysis & Trends
Avanos Medical (AVNS) has 14 years of Income from Continuing Operations data on file, last reported at 5100000.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Continuing Operations fell 22.73% year-over-year to 5100000.0; the trailing twelve-month figure through Mar 2026 stood at 74400000.0 (up 80.43% YoY), and the FY2025 full-year result was 72900000.0, up 81.13% from the prior year.
- Income from Continuing Operations advanced to 5100000.0 in Q1 2026, from 1300000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 11000000.0 in Q3 2022 to a low of 397000000.0 in Q4 2024.
- A 5-year average of 25476470.59 and a median of 4300000.0 in 2024 frame the typical range for Income from Continuing Operations.
- Across the five-year window, Income from Continuing Operations tumbled 3709.09% in 2024 and surged 1220.0% in 2025, its largest moves.
- Tracing AVNS's Income from Continuing Operations over 5 years: stood at 9700000.0 in 2022, then rose by 13.4% to 11000000.0 in 2023, then plunged by 3709.09% to 397000000.0 in 2024, then surged by 99.67% to 1300000.0 in 2025, then jumped by 492.31% to 5100000.0 in 2026.
- Business Quant data shows AVNS's Income from Continuing Operations at 5100000.0 in Q1 2026, 1300000.0 in Q4 2025, and 1400000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Avanos Medical | 1.16 Bn | 1.10 Bn | 94.20 Mn | 5.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.10 Mn |
| Dec 31, 2025 | -1.30 Mn |
| Sep 30, 2025 | -1.40 Mn |
| Jun 30, 2025 | -76.80 Mn |
| Mar 31, 2025 | 6.60 Mn |
| Dec 31, 2024 | -397.00 Mn |
| Sep 30, 2024 | 5.90 Mn |
| Jun 30, 2024 | 4.30 Mn |
| Mar 31, 2024 | 500,000.00 |
| Dec 31, 2023 | 11.00 Mn |
| Sep 30, 2023 | -8.80 Mn |
| Jun 30, 2023 | -4.30 Mn |
| Mar 31, 2023 | -7.80 Mn |
| Dec 31, 2022 | 9.70 Mn |
| Sep 30, 2022 | 11.00 Mn |
| Jun 30, 2022 | 4.80 Mn |
| Mar 31, 2022 | 5.40 Mn |
| Dec 31, 2021 | -25.70 Mn |
| Sep 30, 2021 | -35.30 Mn |
| Jun 30, 2021 | 38.50 Mn |